Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 May;113(5):557-60.
doi: 10.1289/ehp.7647.

Fluoroquinolone-resistant Campylobacter Isolates From Conventional and Antibiotic-Free Chicken Products

Affiliations
Free PMC article
Comparative Study

Fluoroquinolone-resistant Campylobacter Isolates From Conventional and Antibiotic-Free Chicken Products

Lance B Price et al. Environ Health Perspect. .
Free PMC article

Abstract

The use of fluoroquinolones (FQs) in poultry production is an important issue in public health today. In February 2002, two prominent U.S. poultry companies pledged to stop using FQs for flock-wide treatment. One year later, we began a survey of Campylobacter isolates on chicken products from these two companies and from two producers claiming total abstention from antibiotic use. Using both standard isolation methods and new methods modified to enhance detection of FQ-resistant Campylobacter, we compared rates of FQ-resistant Campylobacter among these products. Four major findings were drawn from this study: a) antibiotic-free brands were not more likely to be contaminated with Campylobacter; b) a high percentage of products from the two conventional brands were contaminated with FQ-resistant Campylobacter (43 and 96%); c) these conventional brands had significantly higher odds of carrying resistant strains compared with antibiotic-free products; and d) supplementing media with FQs increased the sensitivity of detecting FQ-resistant strains among mixed populations of Campylobacter, thus reducing a bias toward underestimating the prevalence of FQ-resistant Campylobacter on samples. These results suggest that FQ resistance may persist in the commercial poultry environment in the absence of FQ-selective pressure and that these strains contaminate a larger proportion of foods than reported previously.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

References

    1. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201–1206. - PubMed
    1. Anderson AD, Nelson JM, Rossiter S, Angulo FJ. Public health consequences of use of antimicrobial agents in food animals in the United States. Microb Drug Resist. 2003;9:373–379. - PubMed
    1. Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist. 2001;7:257–261. - PubMed
    1. Bayer HealthCare2004. Healthy Poultry FAQs #7: What Percentage of the US Poultry Population Is Treated with Baytril? Shawnee Mission, KS:Bayer HealthCare. Available: http://www.healthypoultry.com/faqs/index.html#7 [accessed 2 May 2004].
    1. CDC2003. NARMS 2001 Annual Report: Human Isolates Final Report, 2001. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.cdc.gov/narms/annual/2001/01sum.htm [accessed 2 May 2004].

Publication types

LinkOut - more resources

Feedback